IPO: NAV per share grew 3% to GBP 1.14, with strong exits and broad portfolio progress in H1 2026
NAV per share rose 3% to GBP 1.14 in H1 2026, with strong cash realizations and portfolio progress. Key assets like Pfizer's obesity royalty and Oxford Nanopore drove value, while third-party capital and exits advanced toward the GBP 250 million target. Portfolio diversification, disciplined execut…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.